Clinical effect of discordance in empirical treatment of cases with urinary tract infection accompanied by bacteremia
- PMID: 29201522
- PMCID: PMC5687222
- DOI: 10.5152/tud.2017.58538
Clinical effect of discordance in empirical treatment of cases with urinary tract infection accompanied by bacteremia
Abstract
Objective: It has been shown in previous studies that inadequate empirical treatment is associated with mortality in a variety of infections caused by Gram-negative bacteria. In this study, the clinical effect of discordance in empirical treatment was investigated in patients with urinary tract infection (UTI) accompanied by bacteremia.
Material and methods: We retrospectively reviewed the files of adult (>18 years old) patients who were diagnosed with UTI in our clinic between January 2014 and December 2015. Cases in which the same causative microorganism grew in both blood and urine cultures were included in the study. Patients using ceftriaxone and carbapenem as empirical antibiotic therapy (EAT) were compared as two different groups. In cases that the ethiologic agents were extended- spectrum beta lactamase (ESBL)-producing Klebsiella pneumoniae and Escherichia coli isolates, if the microorganism was resistant to initial antibiotic treatment the situation was defined as EAT discordance, and if it was sensitive it was defined as EAT concordance.
Results: After the exclusion criteria were applied, 65 of the 266 cases examined were taken into the study. Clinical and laboratory features of cases of ceftriaxone and carbapenem groups were similar. There was no statistically significant difference between the two groups in terms of hospital stay and survival (p>0.05). Of 28 cases of ESBL-producing E. coli and K. pneumoniae, 18 were EAT discordant and 10 were EAT concordant. Clinical and laboratory features of EAT concordant and EAT discordant groups were similar. No statistically significant difference was found between the two groups in terms of hospital stay and survival (p>0.05).
Conclusion: It was considered that ceftriaxone can still be a viable option in the EAT of UTI, which is accompanied by bacteremia without severe sepsis and septic shock findings. It was concluded that EAT discordance may not have a negative effect on the duration of hospital stay and survival rates in neither total cases nor ESBL positive ones.
Keywords: Bacteremia; empirical antibiotic therapy; urinary tract infection.
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
Figures
Similar articles
-
Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.Ann Emerg Med. 2018 Oct;72(4):449-456. doi: 10.1016/j.annemergmed.2018.05.006. Epub 2018 Jul 3. Ann Emerg Med. 2018. PMID: 29980462
-
Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity.Int J Infect Dis. 2013 Feb;17(2):e120-4. doi: 10.1016/j.ijid.2012.09.008. Epub 2012 Oct 23. Int J Infect Dis. 2013. PMID: 23098812
-
Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.Int Urol Nephrol. 2015 Jul;47(7):1059-66. doi: 10.1007/s11255-015-1018-9. Epub 2015 May 31. Int Urol Nephrol. 2015. PMID: 26026972
-
Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria.Antimicrob Agents Chemother. 2013 Jul;57(7):3092-9. doi: 10.1128/AAC.01523-12. Epub 2013 Apr 22. Antimicrob Agents Chemother. 2013. PMID: 23612198 Free PMC article.
-
Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.Ann Hematol. 2013 Apr;92(4):533-41. doi: 10.1007/s00277-012-1631-y. Epub 2012 Nov 17. Ann Hematol. 2013. PMID: 23161391
Cited by
-
eHealth and mHealth in Antimicrobial Stewardship to Reduce Mortality in Empirical Antimicrobial Therapy and a Systematic Review with a Meta-Analysis of Adequate Therapy.Infect Dis Rep. 2024 Aug 1;16(4):707-723. doi: 10.3390/idr16040054. Infect Dis Rep. 2024. PMID: 39195005 Free PMC article. Review.
-
Poor clinical outcomes associated with suboptimal antibiotic treatment among older long-term care facility residents with urinary tract infection: a retrospective cohort study.BMC Geriatr. 2021 Jul 23;21(1):436. doi: 10.1186/s12877-021-02378-5. BMC Geriatr. 2021. PMID: 34301192 Free PMC article.
References
-
- Nicolle LE. Update in adult urinary tract infection. Curr Infect Dis Rep. 2011;13:552–60. https://doi.org/10.1007/s11908-011-0212-x. - DOI - PubMed
-
- Hsu CY, Fang HC, Chou KJ, Chen CL, Lee PT, Chung HM. The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci. 2006;332:175–80. https://doi.org/10.1097/00000441-200610000-00004. - DOI - PubMed
-
- Ledochowski S, Abraham PS, Jacob X, Dumitrescu O, Lina G, Lepape A, et al. Relevance of blood cultures in acute pyelonephritis in a single-center retrospective study. Intern Emerg Med. 2015;10:607–12. https://doi.org/10.1007/s11739-015-1223-7. - DOI - PubMed
-
- Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis. 2007;45:273–80. https://doi.org/10.1086/519268. - DOI - PubMed
-
- Yılmaz N, Ağuş N, Bayram A, Şamlıoğlu P, Şirin MC, Derici YK, et al. Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008–2014) Turk J Urol. 2016;42:32–6. https://doi.org/10.5152/tud.2016.90836. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources